Fidelity Investments

Fidelity Investments’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Fidelity Investments’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-23,107	Closed	-$68K	–	4418
2018 Q3	$68K	Sell	23,107 -655,870	-97%	-$2.32M	﹤0.01%	2773
2018 Q2	$2.5M	Hold	678,977	–	–	﹤0.01%	2300
2018 Q1	$2.38M	Hold	678,977	–	–	﹤0.01%	2338
2017 Q4	$2.12M	Hold	678,977	–	–	﹤0.01%	2347
2017 Q3	$4.77M	Hold	678,977	–	–	﹤0.01%	2173
2017 Q2	$6.27M	Buy	678,977 +97,500	+17%	+$939K	﹤0.01%	2106
2017 Q1	$6.25M	Sell	581,477 -31,800	-5%	-$325K	﹤0.01%	2120
2016 Q4	$5.16M	Buy	+613,277	New	+$5.43M	﹤0.01%	2171

Other funds holding NVLN

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Healthcare Value Capital Woodcliff Lake, New Jersey $38.5M AUM 24.72% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

David M. Knott $264M AUM 59.23% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return